Acknowledging the low sample numbers, we found that CD200-high BCC tissue samples had lower expression of the NK activation markers NCR3 (NKp30, P = 0.18), NCR2 (NKp44, P = 0.02), and NCR1 (NKp46, P = 0.04). Here, NCR2 is linked to skin basal cell carcinoma.